Kodak cautions there’s ‘substantial doubt’ about its ability to stay in business
ap1 day
© 2025 Improve the News Foundation.
All rights reserved.
Version 6.14.0
The government threw Kodak a lifeline five years ago, and it fumbled it. A deal that would've made it a leading producer of drug ingredients fell apart over a rushed rollout and disclosure missteps that raised concerns with the SEC and Congress. Now Kodak is paying the price for missing its chance.
Kodak emerged from bankruptcy last decade by shifting its focus from cameras and film to commercial and packaging printing. It can adapt again, and the manufacturing plant that's near completion should help the company survive as a maker of regulated pharmaceutical products.